CADL
NASDAQ · Biotechnology
Candel Therapeutics Inc
$8.33
-0.32 (-3.70%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+471.3% upside
Low Target
$33.44
Average Target
$47.59
High Target
$47.92
Current Price
$8.33
Current
$8.33
$8.33
Target
$47.59
$47.59
$33.44
$47.59 avg
$47.92
Scenario Analysis
Bear Case
$33.44
301.4%
Low target
Base Case
$47.59
+471.3%
Avg target
Bull Case
$47.92
+475.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$14.00
-40.5% from high
52-Week Low
$4.35
+91.5% from low
Target vs 52W High
$47.59
+239.9% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.35
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |